SCOPUS 정보 검색 플랫폼

Volumn 15, Issue 7, 2001, Pages 1038-1045

A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group phase III randomized trial

(10) Lauer, S J a Shuster, J J b Mahoney Jr , D H c Winick, N d Toledano, S e Munoz, L e Kiefer, G f Pullen, J D g Steuber, C P c Camitta, B M f

a EMORY UNIVERSITY SCHOOL OF MEDICINE (United States)

b University of Florida (United States)

c BAYLOR COLLEGE OF MEDICINE (United States)

d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER (United States)

e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE (United States)

f Midwest Children's Cancer Center (United States)

g UNIVERSITY OF MISSISSIPPI MEDICAL CENTER (United States)

Author keywords

B precursor ALL; Early intensive chemotherapy; High risk childhood ALL

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; HIGH RISK PATIENT; HUMAN; IRRADIATION; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STOMATITIS; THROMBOCYTOPENIA;

EID: 0034900091 PISSN: 08876924 EISSN: None Source Type: Journal
DOI: 10.1038/sj.leu.2402132 Document Type: Article

Times cited : (26)

References (41)

1
- 0019805238
- Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia of childhood
- (1981) Cancer Res , vol.41 , pp. 4802-4809
- Pullen, D.J.¹ Crist, W.M.² Falletta, J.M.³ Vogler, L.B.⁴ Dowell, B.⁵ Humphrey, G.B.⁶ Blackstock, R.⁷ Eys, J.V.⁸ Cooper, M.D.⁹ Metzgar, R.S.¹⁰ Meydrech, E.F.¹¹

2
- 0021969545
- Prognostic importance of blast cell DNA content in childhood acute lymphocytic leukemia
- (1985) Blood , vol.65 , pp. 1079-1086
- Look, A.T.¹ Roberson, P.K.² Williams, D.L.³ Rivera, G.⁴ Bowman, W.P.⁵ Pui, C.H.⁶ Ochs, J.⁷ Abromowitch, M.⁸ Kalwinsky, D.⁹ Dahl, G.V.¹⁰ George, S.¹¹ Murphy, S.B.¹²

3
- 0024818410
- Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: A report from the Children's Cancer Study Group
- (1989) J Clin Oncol , vol.7 , pp. 1807-1815
- Miller, D.R.¹ Coccia, P.F.² Bleyer, W.A.³ Lukens, J.N.⁴ Siegel, S.E.⁵ Sather, H.N.⁶ Hammond, G.D.⁷

4
- 0025188811
- Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia
- (1990) Blood , vol.76 , pp. 1449-1463
- Pui, C.-H.¹ Crist, W.M.² Look, A.T.³

5
- 0025365178
- Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable features
- (1990) Med Pediatr Oncol , vol.18 , pp. 273-279
- Gaynon, P.S.¹ Bleyer, A.W.² Steinherz, P.G.³ Finklestein, J.Z.⁴ Littman, P.⁵ Miller, D.R.⁶ Reaman, G.⁷ Sather, H.⁸ Hammond, G.D.⁹

6
- 0027303092
- Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia
- (1993) Blood , vol.82 , pp. 343-362
- Pui, C.-H.¹ Behm, F.G.² Crist, W.M.³

7
- 0031056094
- Biology and treatment of acute lymphocytic leukemia in children
- (1997) Sem Oncol , vol.24 , pp. 83-91
- Camitta, B.M.¹ Pullen, J.² Murphy, S.³

8
- 0032839892
- Identification of newly diagnosed children with acute lymphocytic leukemia at high risk for relapse
- (1999) Cancer Res Ther and Control , vol.9 , pp. 101-107
- Shuster, J.J.¹ Camitta, B.M.² Pullen³ Borowitz, M.J.⁴ Carroll, A.J.⁵ Look, A.T.⁶ Mahoney, D.H.⁷ Mahmoud, H.⁸ Lauer, S.J.⁹ Land, V.J.¹⁰

9
- 0022620372
- Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen - A new intensive therapy protocol: A report from the Children's Cancer Study Group
- (1986) J Clin Oncol , vol.4 , pp. 744-752
- Steinherz, P.G.¹ Gaynon, P.² Miller, D.R.³ Reaman, G.⁴ Bleyer, A.⁵ Finklestein, J.⁶ Evans, R.G.⁷ Meyers, P.⁸ Steinherz, L.J.⁹ Sather, H.¹⁰ Hammond, D.¹¹

10
- 0023854188
- Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features; report of the Children's Cancer Study Group Study CCG-193P
- (1988) Am J Pediatr Hematol Oncol , vol.10 , pp. 42-50
- Gaynon, P.S.¹ Bleyer, W.A.² Steinherz, P.G.³ Finklestein, J.Z.⁴ Littman, P.S.⁵ Miller, D.R.⁶ Reaman, G.H.⁷ Sather, H.N.⁸ Hammond, G.D.⁹

11
- 0026067393
- Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy
- (1991) Lancet , vol.337 , pp. 61-66
- Rivera, G.K.¹ Raimondi, S.A.² Hancock, M.L.³ Behm, F.G.⁴ Pui, C.H.⁵ Abramowitch, M.⁶ Mirro J., Jr.⁷ Ochs, J.S.⁸ Look, A.T.⁹ Williams, D.L.¹⁰ Murphy, S.B.¹¹ Dahl, G.V.¹² Kalwinsky, D.K.¹³ Evans, W.E.¹⁴ Kun, L.E.¹⁵ Simone, J.V.¹⁶ Christ, W.M.¹⁷

12
- 0027494884
- Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: A follow-up report of the Children's Cancer Group Study CCG-106
- (1993) J Clin Oncol , vol.11 , pp. 2234-2242
- Gaynon, P.S.¹ Steinherz, P.G.² Bleyer, W.A.³ Ablin, A.R.⁴ Albo, V.C.⁵ Finklestein, J.Z.⁶ Grossman, N.J.⁷ Novak, L.J.⁸ Pyesmany, A.F.⁹ Reaman, G.H.¹⁰ Chappell, R.J.¹¹ Sather, H.N.¹² Hammond, G.D.¹³

13
- 0027514199
- Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia
- (1993) Cancer , vol.71 , pp. 2854-2861
- Lauer, S.J.¹ Camitta, B.M.² Leventhal, B.G.³ Mahoney, D.⁴ Shuster, J.J.⁵ Adair, S.⁶ Casper, J.⁷ Civin, C.⁸ Graham, M.⁹ Keifer, G.¹⁰ Pullen, J.¹¹ Steuber, P.¹² Kamen, B.¹³

14
- 0028152851
- Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
- (1994) Blood , vol.84 , pp. 3122-3133
- Reiter, A.¹ Schrappe, M.² Ludwig, W.D.³ Hiddemann, W.⁴ Sauter, S.⁵ Henze, G.⁶ Zimmermann, M.⁷ Lampert, F.⁸ Havers, W.⁹ Niethammer, D.¹⁰ Odenwald, E.¹¹ Ritter, J.¹² Mann, G.¹³ Welte, K.¹⁴ Gadner, H.¹⁵ Riehm, H.¹⁶

15
- 0028204905
- Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's Hospital acute lymphoblastic leukemia consortium Protocol 85-01
- (1994) J Clin Oncol , vol.12 , pp. 740-747
- Schorin, M.A.¹ Blattner, S.² Gelber, R.D.³ Tarbell, N.J.⁴ Donnelly, M.⁵ Dalton, V.⁶ Cohen, H.J.⁷ Sallan, S.E.⁸

16
- 0028037399
- Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: A Pediatric Oncology Group Study
- (1994) J Clin Oncol , vol.12 , pp. 1939-1945
- Land, V.J.¹ Shuster, J.J.² Crist, W.M.³ Ravindranath, Y.⁴ Harris, M.B.⁵ Krance, R.A.⁶ Pinkel, D.⁷ Pullen, D.J.⁸

17
- 0028365137
- Intensive intravenous methotrexate and mercaptopurine treatment of high-risk non-T acute lymphocytic leukemia
- (1994) J Clin Oncol , vol.12 , pp. 1383-1389
- Camitta, B.M.¹ Mahoney, D.² Levethal, B.G.³ Lauer, S.J.⁴ Shuster, J.J.⁵ Adair, S.⁶ Civin, C.⁷ Munoz, L.⁸ Steuber, P.⁹ Strother, D.¹⁰ Kamen, B.A.¹¹

18
- 0029739087
- Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia
- (1996) J Clin Oncol , vol.14 , pp. 2803-2811
- Winick, N.¹ Shuster, J.J.² Bowman, W.P.³ Borowitz, M.⁴ Farrow, A.⁵ Jacaruso, D.⁶ Buchanan, G.R.⁷ Kamen, B.A.⁸

19
- 0031887690
- Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: A report from the Children's Cancer Group
- (1998) J Clin Oncol , vol.16 , pp. 920-930
- Nachman, J.¹ Sather, H.N.² Cherlow, J.M.³ Sensel, M.G.⁴ Gaynon, P.S.⁵ Lukens, J.N.⁶ Wolff, L.⁷ Trigg, M.E.⁸

20
- 0031856144
- Improved survival with early intensification: Combined results from Medical Research Council Childhood ALL randomized trials, UKALL X and UKALL XI
- (1998) Leukemia , vol.12 , pp. 1031-1036
- Richards, S.¹ Burrett, J.² Hann, I.³ Chessells, J.⁴ Hill, F.⁵ Bailey, C.⁶

21
- 0027406656
- Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: A Children's Cancer Group Phase III Trial
- (1993) J Clin Oncol , vol.11 , pp. 527-537
- Tubergen, D.G.¹ Gilchrist² O'Brien, R.T.³ Coccia, P.F.⁴ Sather, H.N.⁵ Waskerwitz, M.J.⁶ Hammond, G.D.⁷

22
- 0030041119
- Treatment related deaths during induction and in first remission in acute lymphoblastic leukemia: MRCUKALLX
- (1996) Arch Dis Child , vol.74 , pp. 101-107
- Wheeler, K.¹ Chessells, J.M.² Bailey, C.C.³ Richards, S.M.⁴

23
- 0019952884
- Rationale for the use of alternating non- cross-resistant chemotherapy
- (1982) Cancer Treat Rep , vol.66 , pp. 439-449
- Goldie, J.H.¹ Coldman, A.J.² Gudauskas, G.A.³

24
- 0027479966
- Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: Experience of the Pediatric Oncology Group
- (1993) Rec Results Cancer Res. , vol.131 , pp. 257-267
- Borowitz, M.J.¹ Carroll, A.J.² Shuster, J.J.³ Look, A.T.⁴ Behm, F.G.⁵ Pullen, D.J.⁶ Land, V.J.⁷ Steuber, P.⁸ Crist, W.M.⁹

25
- 0026518781
- Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-precursor cell acute lymphoblastic leukemia
- A Pediatric Oncology Group Study.
- (1992) J Clin Oncol , vol.10 , pp. 606-613
- Trueworthy, R.¹ Shuster, J.² Look, T.³ Crist, W.⁴ Borowitz, M.⁵ Carroll, A.⁶ Frankel, L.⁷ Harris, M.⁸ Wagner, H.⁹ Haggard, M.¹⁰ Mosijczuk, A.¹¹ Pullen, J.¹² Steuber, P.¹³ Land, V.¹⁴

26
- 0004365731
- A Pediatric Oncology Group classification protocol for acute lymphocytic leukemia (ALinC 13): Immunologic phenotypes and correlation with treatment results
- Murphy SB, Gilbert JR (eds). Elsevier: Amsterdam
- (1994) Leukemia Research: Advances in Cell Biology and Treatment , pp. 221-239
- Pullen, D.J.¹ Crist, W.M.² Falletta, J.M.³ Boyette, J.M.⁴ Roper, M.⁵ Dowell, B.⁶ van Eys, J.⁷ Humphrey, G.B.⁸ Head, D.⁹ Brock, B.L.¹⁰ Blackstock, R.¹¹ Metzgar, R.S.¹² Cooper, M.D.¹³

27
- 0025328804
- Poor prognosis of children with pre-B acute lymphoblastic leukemia with the t (1;19) (q23;p13): A Pediatric Oncology Group Study
- (1990) Blood , vol.76 , pp. 117-122
- Crist, W.M.¹ Carroll, A.² Shuster, J.J.³ Behm, F.G.⁴ Whitehead, M.⁵ Vietti, T.J.⁶ Look, A.T.⁷ Mahoney, D.⁸ Ragab, A.⁹ Pullen, D.J.¹⁰ Land, V.J.¹¹

28
- 0026065816
- Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia
- (1991) Blood , vol.77 , pp. 435-439
- Fletcher, J.A.¹ Lynch, E.A.² Kimball, V.M.³ Donnelly, M.⁴ Tantravahi, R.⁵ Sallan, S.E.⁶

29
- 0004069130
- CRC Press: Boca Raton
- (1992) Handbook of Sample Size Guidelines for Clinical Trials
- Shuster, J.J.¹

30
- 33845382806
- Nonparametric estimation from incomplete observation
- (1958) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

31
- 0017365573
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples
- (1977) Br J Cancer , vol.35 , pp. 1-39
- Peto, R.¹ Pike, M.C.² Armitage, P.³ Breslow, N.E.⁴ Cox, D.R.⁵ Howard, S.V.⁶ Mantel, N.⁷ McPherson, K.⁸ Peto, J.⁹ Smith, P.G.¹⁰

32
- 0000336139
- Regression models and life-tables
- (1972) J R Stat Soc , vol.34 , pp. 187-220
- Cox, D.R.¹

33
- 0344333442
- Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute Pediatric Oncology Group Phase III Trial
- (1998) J Clin Oncol , vol.16 , pp. 246-254
- Mahoney, D.H.¹ Shuster, J.² Nitschke, R.³ Lauer, S.J.⁴ Winick, N.⁵ Steuber, C.P.⁶ Camitta, B.⁷

34
- 0344542098
- Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy-A Pediatric Oncology Group Study
- (1998) J Clin Oncol , vol.16 , pp. 1712-1722
- Mahoney, D.H.¹ Shuster, J.J.² Nitschke, R.³ Lauer, S.J.⁴ Steuber, C.P.⁵ Winick, N.⁶ Camitta, B.⁷

35
- 9044226139
- Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia
- (1996) J Clin Oncol , vol.14 , pp. 18-24
- Smith, M.¹ Arthur, D.² Camitta, B.³ Carroll, A.J.⁴ Crist, W.⁵ Gaynon, P.⁶ Gelber, R.⁷ Heerema, N.⁸ Korn, E.L.⁹ Link, M.¹⁰ Murphy, S.¹¹ Pui, C.H.¹² Pullen, J.¹³ Reamon, G.¹⁴ Sallan, S.E.¹⁵ Sather, H.¹⁶ Shuster, J.¹⁷ Simon, R.¹⁸ Trigg, M.¹⁹ Tubergen, D.²⁰ Uckun, F.²¹ Ungerleider, R.²² more..

36
- 0031904557
- Consolidation therapy with antimetabolite - Based therapy in standard risk acute lymphocytic leukemia of childhood: A Pediatric Oncology Group Study
- (1998) J Clin Oncol , vol.16 , pp. 2840-2847
- Harris, M.B.¹ Shuster, J.J.² Pullen, J.³ Borowitz, M.J.⁴ Carroll, A.J.⁵ Behm, F.G.⁶ Land, V.J.⁷

37
- 0028813641
- Intensification of treatment and survival in all children with lymphoblastic Leukemia
- Results of UR Medical Research Council trial UKALL X.
- (1995) Lancet , vol.345 , pp. 143-147
- Chessells, J.M.¹ Bailey, C.² Richards, S.M.³

38
- 0026563349
- Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children
- Long-term results of St. Jude's Total Therapy Study X.
- (1992) Leukemia , vol.6 , pp. 150-157
- Pui, C.H.¹ Simone, J.V.² Hancock, M.L.³ Evans, W.E.⁴ Williams, D.L.⁵ Bowman, W.P.⁶ Dahl, G.V.⁷ Dodge, R.K.⁸ Ochs, J.⁹ Abromowitch, M.¹⁰ Rivera, G.K.¹¹

39
- 0042132423
- Expression of a multi-drug resistant gene in human tumors and tissues
- (1987) Proc Natl Acad Sci USA , vol.84 , pp. 265-269
- Fojo, A.T.¹ Ueda, K.² Slamon, D.J.³ Poplack, D.G.⁴ Gottesman, M.M.⁵ Pastan, I.⁶

40
- 0021952694
- Isolation and characterization of an anthracycline-resistant human leukemia cell line
- (1985) Cancer Res , vol.45 , pp. 3657-6662
- Bhalla, K.¹ Hindenburg, A.² Taub, R.N.³ Grant, S.⁴

41
- 0004434997
- DNA topoisomerase as targets of anticancer drug action
- (1989) Proc Am Assoc Cancer Res , vol.30 , pp. 669-671
- Kohn, W.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.